glutathione peroxidase drugbank Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of 1 in Chronic Obstructive Pulmonary Disease | Pharmaceutical Research The glutathione peroxidase family: Discoveries

Baptista MAS, Merchant K, Barrett T, Bhargava S, Bryce DK, Ellis JM, Estrada AA, Fell MJ, Fiske BK, Fuji RN et al (2020) LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits

Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro

Under accelerated conditions (up to 1 month of storage at 40 C), no fibrillation or substantial covalent oligomerization was displayed by peptide 40 at concentrations ranging from 1 to 10 mg/mL in common buffers (histidine, phosphate, and tris(hydroxymethyl)aminomethane [Tris] buffers) at pH values in the range 6.1 to 7.4 (Table )

Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer

In contrast, their expression was negatively correlated with that of TWIST1 , a mesenchymal marker, in these HCC patients (Fig